Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

By Zhang M.   Methot D.   Poppa V.   Fujio Y.   Walsh K.   Murry C.E.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 5, 2001-05 ,pp. : 907-921

Academic Press

Access to resources Recommend Favorite

Cause of death during 13 years after coronary artery bypass grafting with emphasis on cardiac death

By Herlitz Johan   Brandrup-Wognsen Gunnar   Caidahl Kenneth   Haglid-Evander Maria   Hartford Marianne   Karlson Björn   Karlsson Thomas   Sjöland Helén  

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 5, 2004-10 ,pp. : 283-286

Informa Healthcare

Access to resources Recommend Favorite

Mortality, Risk Indicators, Mode and Place of Death and Symptoms of Angina Pectoris in the Five Years after Coronary Artery Bypass Grafting in Patients With and Without a History of Hypertension

By HERLITZ JOHAN   BRANDRUP-WOGNSEN GUNNAR   KARLSON BJÖRN W.   SJÖLAND HELÉN   KARLSSON THOMAS   CAIDAHL KENNETH   HARTFORD MARIANNE   HAGLID MARIA  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 200-206

Informa Healthcare

Access to resources Recommend Favorite

Reduction of protein synthesis and statin-induced cardiomyocyte cell death

By Rabkin Simon   Lodha Parth   Kong Jennifer  

Cardiovascular Toxicology, Vol. 7, Iss. 1, 2007-03 ,pp. : 1-9

Humana Press, Inc

Access to resources Recommend Favorite

Regulation of MEF2 by p38 MAPK and Its Implication in Cardiomyocyte Biology

By Han J.   Molkentin J.D.  

Trends in Cardiovascular Medicine, Vol. 10, Iss. 1, 2000-01 ,pp. : 19-22

Elsevier

Access to resources Recommend Favorite